Filing for a Patent Versus Keeping Your Invention a Trade Secret
Harvard Business Review
NOVEMBER 21, 2013
Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. Budget constraints and the costs for filing a patent force a smart evaluation of your options. This may lead inventors to rely more on the dual strategy of patent and trade secret protection for a single invention.
8 
Let's personalize your content